Skip to main content

HB 429 — Delaware

AN ACT TO AMEND TITLE 18 OF THE DELAWARE CODE RELATING TO THE STEP THERAPY EXCEPTION PROCESS.

Signed into law 153 session House

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

This Act modernizes Delaware law by adding modern medical treatment options biologics or biosimilars to the step therapy exception process. The current law was passed before biosimilars were widely available. Biosimilars are to biologics what generic drugs are to traditional drugs once their exclusivity expires.
This revision adds an exclusion to step therapy protocol exceptions for interchangeable biologics and biosimilars.

Official abstract, as published by the legislature.

  • HB 429 is a bill in the Delaware House, 153 session, introduced May 19, 2026.
  • Sponsored by Melissa Minor-Brown and Marie Pinkney, with 12 cosponsors.
  • Current status: signed into law.
  • Most recent action (July 23, 2026): Signed by Governor.
  • 2 recorded votes; the most recent, on June 24, 2026, passed 21-0.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Melissa Minor-Brown, Marie Pinkney

Cosponsors (12): Debra Heffernan, Kendra Johnson, Eric Morrison, Frank Burns, Kerri Evelyn Harris, Alonna Berry, William J. Carson, Larry Lambert, Melanie Ross Levin, Claire Snyder-Hall, Ray Seigfried, Nicole Poore

History

  1. Introduced, completed
  2. Passed House, completed
  3. Passed Senate, completed
  4. Sent to Governor, completed
  5. Signed into law, completed, current stage
  1. House Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House Milestone
  2. House Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 3 Favorable, 6 On Its Merits
  3. House Passed By House. Votes: 38 YES 1 NO 2 ABSENT Milestone

    Passage: 38 yes 1 no, 2 other Passed, 97% yes

  4. Senate Assigned to Banking, Business, Insurance & Technology Committee in Senate Milestone
  5. Senate Reported Out of Committee (Banking, Business, Insurance & Technology) in Senate with 5 On Its Merits
  6. Senate Passed By Senate. Votes: 21 YES Milestone

    Passage: 21 yes 0 no Passed, 100% yes

  7. Governor Signed by Governor Milestone Latest

Source: Open States. Last checked November 5, 2026. How we keep this accurate ›